Keeping Track: FDA Approves First Rx DHEA, Receives Applications For Midostaurin, Gesulkumab, Biosimilar Avastin
The latest drug development news and highlights from our FDA Performance Tracker.
You may also be interested in...
"We've identified the patient population that would benefit from this," said Vitaly Kushnir, of the Center for Human Reproduction. Fertility Nutraceuticals-backed study shows subjects' Female Sexual Function Index scores increased by 17% for desire, 12% for arousal and 8% for lubrication.
Dynavax has already received two complete response letters for its hepatitis B vaccine; more patients who received Heplisav died or experienced cardiovascular events compared with the competitor arm.
The latest drug development news and US FDA highlights from our Performance Tracker.